Image

Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes

Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes

Recruiting
11-14 years
All
Phase N/A

Powered by AI

Overview

Type 1 diabetes is becoming more common in Kuwaiti and Arab adolescents. Many young people with this condition struggle to keep their blood glucose levels under control, which can lead to diabetes-related complications and affect their quality of life.

The goal of this clinical trial is to evaluate the effectiveness of a structured educational program on glycemic control among Arab adolescents with type 1 diabetes aged 11 to 14 years.

Participants will be randomly assigned to one of two groups. The intervention group will receive the structured education program, and the control group will continue with standard care.

All participants will undergo assessments that include:

  • collecting demographic and diabetes management data
  • measuring weight and height
  • measuring HbA1c levels and lipid profile
  • filling out questionnaires on quality of life, carbohydrate and insulin dosing knowledge, physical activity
  • collecting dietary intake
  • providing AGP report

Participants in the intervention group will additionally be required to:

  • attend the program for 4 consecutive days, one day for parents and three days for children
  • fill out 3-day food diary records during the program
  • attend a refresher course after 6 months

Participants in the control group will have the opportunity to participate in the program after approximately six months.

Eligibility

Inclusion Criteria:

  • Arab adolescents
  • Males and females aged 11 to 14 years.
  • Have been diagnosed with type 1 diabetes for at least 6 months.
  • Wearing a continuous glucose monitor (CGM).
  • Individuals and their parents must be able to join the entire duration of the study.
  • Individuals and their parents must voluntarily provide consent and assent.

Exclusion Criteria:

  • Presence of learning disabilities or any known psychological issues.
  • Attendance at any diabetes education or carbohydrate counting programs within the six months preceding the study.

Study details
    Type 1 Diabetes (T1D)
    Type 1 Diabetes Mellitus (T1DM)

NCT06984133

Dasman Diabetes Institute

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.